Legato Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Legato Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-52,636	Closed	-$828K	–	636
2024 Q1	$828K	Buy	+52,636	New	+$810K	0.1%	325

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Legato Capital Management's DCPH Position: Q2 2024 in Review

Legato Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 52,636 shares — an estimated $828K sold.

Legato Capital Management first reported a position in DCPH in Q1 2024 and held it in 1 quarter. The position peaked at $828K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Legato Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Legato Capital Management sold 52,636 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $828K.
Legato Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Legato Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $828K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Legato Capital Management's 13F filing for Q2 2024, filed 26 Jul 2024.